Literature DB >> 9667701

Co-existing biliary anomalies and anatomical variants in choledochal cyst.

T Todani1, Y Watanabe, A Toki, K Ogura, Z Q Wang.   

Abstract

BACKGROUND: Excision is the treatment of choice for choledochal cyst, and free bile drainage is essential to avoid ascending cholangitis. However, anastomosis between the relatively narrow common hepatic duct and bowel (conventional anastomosis) in case of type IV-A cyst, co-existing biliary anomalies and anatomical variations may cause ascending cholangitis resulting from insufficient biliary decompression.
METHODS: One hundred and four patients with choledochal cyst were treated by cyst excision. Conventional anastomosis was performed in 22 patients and hilar anastomosis in 82.
RESULTS: An anastomotic stricture developed in nine of the 22 conventional anastomosis cases and all required reoperation. Of the 82 hilar anastomosis cases, only one required reoperation for a primary stricture. Co-existing biliary anomalies and anatomical variants were seen in 26 patients: (1) primary stricture in 18; (2) aberrant posterior duct in two; (3) low confluence of the hepatic ducts in two; (4) aberrant hepatic artery in two; and (5) very small bile duct in two. All 26 patients underwent widening of the ductal lumen (ductoplasty) or additional procedures.
CONCLUSION: Complete removal of the extrahepatic bile duct and a wide hilar anastomosis is essential to prevent ascending cholangitis. Ductoplasty or additional procedure can be performed only at the hilum.

Entities:  

Mesh:

Year:  1998        PMID: 9667701     DOI: 10.1046/j.1365-2168.1998.00697.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  19 in total

1.  Choledochal Cystic Diseases.

Authors:  Stephen D. Bruns; Thomas A. Broughan
Journal:  Curr Treat Options Gastroenterol       Date:  2001-04

Review 2.  Japanese clinical practice guidelines for pancreaticobiliary maljunction.

Authors:  Terumi Kamisawa; Hisami Ando; Masafumi Suyama; Mitsuo Shimada; Yuji Morine; Hiroshi Shimada
Journal:  J Gastroenterol       Date:  2012-06-22       Impact factor: 7.527

3.  Choledochal Cyst with Aberrant Right Posterior Sectoral Duct.

Authors:  Sumitoj Singh; Narinder Pal Singh; Anirudh Goyal; Satpal Hans; Sudhir Khichy
Journal:  Indian J Surg       Date:  2013-05-17       Impact factor: 0.656

4.  Variations in biliary ductal and hepatic vascular anatomy and their relevance to the surgical management of choledochal cysts.

Authors:  Richa Lal; Anu Behari; Ranjit Hari Vijaya Hari; Sadiq S Sikora; Surender Kumar Yachha; Vinay Kumar Kapoor
Journal:  Pediatr Surg Int       Date:  2013-06-22       Impact factor: 1.827

5.  Recurrence of biliary tract obstructions after primary laparoscopic hepaticojejunostomy in children with choledochal cysts.

Authors:  Mei Diao; Long Li; Wei Cheng
Journal:  Surg Endosc       Date:  2015-12-10       Impact factor: 4.584

6.  Dilatation of the Proximal Cystic Duct: Is It a Variant to "Type VI" Choledochal Cyst?

Authors:  Christos Kaselas; Dimitrios Patoulias; Ioannis Patoulias; Ioannis Spyridakis
Journal:  J Clin Diagn Res       Date:  2016-06-01

7.  Laparoscopically assisted extrahepatic bile duct excision with ductoplasty and a widened hepaticojejunostomy for complicated hepatobiliary dilatation.

Authors:  Suolin Li; Wenbo Wang; Zengwen Yu; Weili Xu
Journal:  Pediatr Surg Int       Date:  2014-04-10       Impact factor: 1.827

8.  Bile infection contributes to intrahepatic calculi formation after excision of choledochal cysts.

Authors:  Kenitiro Kaneko; Hisami Ando; Takahiko Seo; Yasuyuki Ono; Keiko Ochiai; Yukio Ogura
Journal:  Pediatr Surg Int       Date:  2005-01       Impact factor: 1.827

9.  Laparoscopic redo hepaticojejunostomy for children with choledochal cysts.

Authors:  Mei Diao; Long Li; Wei Cheng
Journal:  Surg Endosc       Date:  2016-04-28       Impact factor: 4.584

10.  Management of adult choledochal cysts--a 15-year experience.

Authors:  S R Banerjee Jesudason; Mark Ranjan Jesudason; Rajiv Paul Mukha; Frederick L Vyas; Sanjay Govil; John C Muthusami
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.